01—Abstract
Summary
Summary of the 8-K filed August 9, 2019. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. announced a board appointment to fill a vacancy created by the passing of director David J.
Wescott. Yra G. Harris has been appointed to the Class B-1 director position, effective August 7, 2019, and will serve until the company's next annual shareholder meeting.
Mr. Harris was previously a nominee for the Class B-1 director role in the 2019 annual election. This appointment is primarily a governance update, ensuring the board maintains its full complement of directors.
Investors should note that Mr. Harris will be compensated according to the standard terms for non-executive directors, indicating no immediate change to the company's compensation structure for its board members. This filing does not contain any material financial or operational updates.
02—Key points
Key Highlights
- CME Group Inc. appointed Yra G. Harris to its Board of Directors on August 7, 2019.
- The appointment fills a vacancy in the Class B-1 director position due to the passing of David J. Wescott.
- Mr. Harris will serve until the next annual meeting of shareholders.
- He was a Class B-1 nominee in the 2019 annual election of directors.
- Mr. Harris will receive compensation on the same terms as other non-executive directors.
03—Questions
Frequently Asked Questions
What is the main reason for this 8-K filing?
This 8-K filing is primarily to inform investors about the appointment of a new director to fill a vacant board seat.
Who is the newly appointed director and what is their role?
Yra G. Harris has been appointed as a Class B-1 director. He will serve on the Board of Directors until the next annual shareholder meeting.
How will the new director be compensated?
Mr. Harris will be compensated for his board service on the same terms as other non-executive directors.
Does this filing indicate any changes in CME Group's financial performance or business operations?
No, this filing is related to a board composition change and does not provide any information on the company's financial performance or operational updates.
04—Continue